Phenotyping Occupational Asthma Caused by Acrylates in a Multicenter Cohort Study.

Acrylate Cyanoacrylate Fractional exhaled nitric oxide Low-molecular-weight agent Methacrylate Occupational asthma

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
03 2020
Historique:
received: 27 09 2019
revised: 11 10 2019
accepted: 15 10 2019
pubmed: 5 11 2019
medline: 15 5 2021
entrez: 4 11 2019
Statut: ppublish

Résumé

While acrylates are well-known skin sensitizers, they are not classified as respiratory sensitizers although several cases of acrylate-induced occupational asthma (OA) have been reported. To evaluate the characteristics of acrylate-induced OA in a large series of cases and compare those with OA induced by other low-molecular-weight (LMW) agents. Jobs and exposures, clinical and functional characteristics, and markers of airway inflammation were analyzed in an international, multicenter, retrospective cohort of subjects with OA ascertained by a positive inhalation challenge to acrylates (n = 55) or other LMW agents (n = 418) including isocyanates (n = 125). Acrylate-containing glues were the most prevalent products, and industrial manufacturing, dental work, and beauty care were typical occupations causing OA. Work-related rhinitis was more common in acrylate-than in isocyanate-induced asthma (P < .001). The increase in postchallenge fractional exhaled nitric oxide was significantly greater in acrylate-induced OA (26.0; 8.2 to 38.0 parts per billion [ppb]) than in OA induced by other LMW agents (3.0; -1.0 to 10.0 ppb; P < .001) or isocyanates (5.0; 2.0 to 16.0 ppb; P = .010). Multivariable models confirmed that OA induced by acrylates was significantly and independently associated with a postchallenge increase in fractional exhaled nitric oxide (≥17.5 ppb). Acrylate-induced OA shows specific characteristics, concomitant work-related rhinitis, and exposure-related increases in fractional exhaled nitric oxide, suggesting that acrylates may induce asthma through different immunologic mechanisms compared with mechanisms through which other LMW agents may induce asthma. Our findings reinforce the need for a reevaluation of the hazard classification of acrylates, and further investigation of the pathophysiological mechanisms underlying their respiratory sensitizing potential.

Sections du résumé

BACKGROUND
While acrylates are well-known skin sensitizers, they are not classified as respiratory sensitizers although several cases of acrylate-induced occupational asthma (OA) have been reported.
OBJECTIVE
To evaluate the characteristics of acrylate-induced OA in a large series of cases and compare those with OA induced by other low-molecular-weight (LMW) agents.
METHODS
Jobs and exposures, clinical and functional characteristics, and markers of airway inflammation were analyzed in an international, multicenter, retrospective cohort of subjects with OA ascertained by a positive inhalation challenge to acrylates (n = 55) or other LMW agents (n = 418) including isocyanates (n = 125).
RESULTS
Acrylate-containing glues were the most prevalent products, and industrial manufacturing, dental work, and beauty care were typical occupations causing OA. Work-related rhinitis was more common in acrylate-than in isocyanate-induced asthma (P < .001). The increase in postchallenge fractional exhaled nitric oxide was significantly greater in acrylate-induced OA (26.0; 8.2 to 38.0 parts per billion [ppb]) than in OA induced by other LMW agents (3.0; -1.0 to 10.0 ppb; P < .001) or isocyanates (5.0; 2.0 to 16.0 ppb; P = .010). Multivariable models confirmed that OA induced by acrylates was significantly and independently associated with a postchallenge increase in fractional exhaled nitric oxide (≥17.5 ppb).
CONCLUSIONS
Acrylate-induced OA shows specific characteristics, concomitant work-related rhinitis, and exposure-related increases in fractional exhaled nitric oxide, suggesting that acrylates may induce asthma through different immunologic mechanisms compared with mechanisms through which other LMW agents may induce asthma. Our findings reinforce the need for a reevaluation of the hazard classification of acrylates, and further investigation of the pathophysiological mechanisms underlying their respiratory sensitizing potential.

Identifiants

pubmed: 31678289
pii: S2213-2198(19)30908-0
doi: 10.1016/j.jaip.2019.10.017
pii:
doi:

Substances chimiques

Acrylates 0
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

971-979.e1

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Investigateurs

None Vandenplas
Catherine Rifflart (C)
Pavlina Klusackova (P)
David Sherson (D)
Hille Suojalehto (H)
Irmeli Lindström (I)
Pirjo Hölttä (P)
Paula Kauppi (P)
Frédéric de Blay (F)
Laura Hurdubaea (L)
Rolf Merget (R)
Alexandra M Preisser (AM)
Volker Harth (V)
Piero Maestrelli (P)
Paola Mason (P)
Gianna Moscato (G)
Patrizia Pignatti (P)
Pierluigi Paggiaro (P)
Donatella Talini (D)
Marco dell'Omo (M)
Ilenia Foletti (I)
Cecilie Svanes (C)
Jorunn Kirkeleit (J)
Jolanta Walusiak-Skorupa (J)
Marta Wiszniewska (M)
Xavier Munoz (X)
Christian Romero-Mesones (C)
Joaquin Sastre (J)
Mar Fernandez-Nieto (M)
Santiago Quirce (S)
Marta Sanchez-Jareno (M)
Paul Cullinan (P)
Julie Cannon (J)
Sherwood Burge (S)
Vicky Moore (V)
Jennifer Hoyle (J)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Hille Suojalehto (H)

Finnish Institute of Occupational Health, Helsinki, Finland.

Katri Suuronen (K)

Finnish Institute of Occupational Health, Helsinki, Finland.

Paul Cullinan (P)

Department of Occupational and Environmental Medicine, Royal Brompton Hospital and Imperial College (NHLI), London, United Kingdom. Electronic address: p.cullinan@imperial.ac.uk.

Irmeli Lindström (I)

Finnish Institute of Occupational Health, Helsinki, Finland.

Joaquin Sastre (J)

Department of Allergy, Fundacion Jimenez Dıaz and CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Jolanta Walusiak-Skorupa (J)

Department of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, Lodz, Poland.

Xavier Munoz (X)

Hospital Vall d'Hebron, Universitat Autonoma de Barcelona and CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.

Donatella Talini (D)

Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy.

Pavlina Klusackova (P)

Department of Occupational Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Vicky Moore (V)

Occupational Lung Disease Unit, Birmingham Heartlands Hospital, Birmingham, United Kingdom.

Rolf Merget (R)

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Ruhr University, Bochum, Germany.

Cecilie Svanes (C)

Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Paola Mason (P)

Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Marco dell'Omo (M)

Department of Medicine, Section of Occupational Medicine, Respiratory Diseases and Occupational and Environmental Toxicology, University of Perugia, Perugia, Italy.

Gianna Moscato (G)

Department of Public Health, Experimental and Forensic Medicine, Specialization School in Occupational Medicine, University of Pavia, Pavia, Italy.

Santiago Quirce (S)

Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ) and CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Jennifer Hoyle (J)

Department of Respiratory Medicine, North Manchester General Hospital, Manchester, United Kingdom.

David Sherson (D)

Department of Pulmonary Medicine and Occupational Medicine, Odense University Hospital, Odense, Denmark.

Alexandra Preisser (A)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Martin Seed (M)

Centre for Occupational and Environmental Health, The University of Manchester, Manchester, United Kingdom.

Catherine Rifflart (C)

Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.

Julien Godet (J)

Groupe Méthode Recherche Clinique, Pôle de Santé Publique, Strasbourg University, Strasbourg, France.

Frédéric de Blay (F)

Division of Asthma and Allergy, Department of Chest Diseases, University Hospital of Strasbourg, Strasbourg, France; Fédération de Médecine translationnelle, Strasbourg University, Strasbourg, France.

Olivier Vandenplas (O)

Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH